Drug Information

Drug General Information
Drug ID
D08TFH
Former ID
DNC013793
Drug Name
Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529498]
Structure
Download
2D MOL

3D MOL
Formula
C22H19NO2
Canonical SMILES
C1C(CC2=CC=CC=C21)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=C4
InChI
1S/C22H19NO2/c24-22(23-20-13-17-9-4-5-10-18(17)14-20)25-21-12-6-11-19(15-21)16-7-2-1-3-8-16/h1-12,15,20H,13-14H2,(H,23,24)
InChIKey
UEEYQEMKIXZIGW-UHFFFAOYSA-N
PubChem Compound ID
24881740
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529498]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.